Free tracked shipping
LYZE LABS
Lyze Labs CBL-514 20 mg kit - Research Use Only
GLP-1 and metabolic

CBL-514

CBL-514 is a small-molecule fat-reduction injection from Caliway, now in phase 3 trials. Each kit is 10 vials of 20 mg from one batch.

10 vials from one batchFreeze-dried powder4.8 on Trustpilot

Also known as CBL514

For research and laboratory use only. Not for human consumption.

$365a kit

Choose how many kits

Mix any kits. Every kit in your cart counts toward the price. More than 50, or a custom size? Ask for a quote

1
Batch
Delivery
Free tracked shipping to 150+ countries. Delivery guaranteed. How delivery works
Report
Batch report after the first test · Delivery photos
Guarantee
Once this compound's first Certificate of Analysis is published at /lab-results, the same below-COA-purity reship guarantee applies.
Help
A person answers on WhatsApp, even at 3 a.m. your time.

CBL-514: Key Facts

CBL-514 is a fat loss research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 1 format. Batch certificates of analysis are published on the lab-results page as verification completes.

CompoundCBL-514
Research categoryGLP-1 and metabolic
Available formats20mg*10vials
Strength shown20 mg
PurityPublished on the lab-results page as verification completes
Test methodHPLC + mass spectrometry
Certificate of analysisPublished on the lab-results page after the first test
Intended useLaboratory research use only. Not for human consumption.
HandlingSupplied lyophilized, store per the stability guide

Good to know

All ten vials are from one batch. One batch report covers the whole kit, so the first vial matches the last.

Your price drops with every kit. Any mix counts, up to 42% off at 50 kits.

About This Product

What is CBL-514?

CBL-514 is a small-molecule drug, not a peptide. Caliway Biopharmaceuticals develops it to shrink fat in one area, such as the belly, without surgery.

In trials, it was injected into the fat under the skin. The fat cells it reached died off by apoptosis, a planned and orderly cell death, and the fat layer got thinner.

How does CBL-514 work?

  • Targets fat cells: it starts apoptosis, a planned and orderly cell death, in fat cells.
  • Lipolysis: researchers call it a lipolysis agent, meaning it breaks down the fat stored in those cells.
  • No necrosis seen: the phase 2 studies saw no necrosis (tissue death) and no nerve injury.

What do researchers study it for?

  • Reducing belly fat under the skin, without surgery
  • Cellulite
  • Dercum's disease, a rare condition with painful fatty lumps

Key studies

Status (November 2026)

Investigational; not an approved medicine. The first phase 3 trial, SUPREME-01, began enrolling in the US and Canada in September 2026, and a second phase 3 trial is planned.

Quality Standards

  • Form: freeze-dried powder in sealed vials
  • Storage: refrigerator for near-term use, minus 20 degrees Celsius long-term
  • Batch report: goes up on /lab-results once testing of the first batch is complete

Related research

For research purposes only. Not for human consumption or therapeutic use.

Research Context for CBL-514

Lipolysis and Fat Metabolism Research Context

Fat metabolism research peptides target lipolysis, mitochondrial fatty acid oxidation, brown adipose activation, or direct effects on adipocyte viability. Research protocols measure body composition, lipid panel markers, and tissue-specific fat mobilization under defined experimental conditions.

CBL-514 ships as a lyophilized research reagent through the LyzeLabs™ catalog in the GLP-1 and metabolic category, available as a single research-grade format. Verified LyzeLabs compounds publish their full HPLC chromatogram and mass spectrometry confirmation for each batch on the LyzeLabs lab results page; this compound's analytical data is published there as it completes verification.

Other Compounds in the GLP-1 and metabolic Category

Frequently Asked Questions

Is CBL-514 a peptide?

No. CBL-514 is a small-molecule drug developed by Caliway Biopharmaceuticals. It sits in our fat-loss range next to peptides studied for the same goal.

How is CBL-514 different from GLP-1 compounds?

GLP-1 compounds such as semaglutide lower appetite and act across the whole body. CBL-514 is studied for local fat: it is injected into one area and acts on the fat cells there.

Is CBL-514 approved?

No. As of November 2026 it is in phase 3 trials and is not an approved medicine. The CBL-514 sold here is research material for laboratory use only.

What comes in a CBL-514 kit?

Ten sealed vials of freeze-dried CBL-514, all from one batch, at 20 mg a vial.

How should CBL-514 be stored?

Keep the sealed vials at -20°C. Once mixed, keep it at 2 to 8°C and use it within 14 days.

How does CBL-514 ship?

CBL-514 ships as a freeze-dried powder in sealed vials, which stays stable at room temperature for the trip. Every order goes out in plain packaging with tracking, and most arrive in 7 to 14 days. Store it in the freezer at -20°C once it arrives.

1 kit

$365